Effect of glycated hemoglobin index and mean arterial pressure on acute ischemic stroke prognosis after intravenous thrombolysis with recombinant tissue plasminogen activator

被引:17
|
作者
Liu, Shi-Ying [1 ,2 ]
Cao, Wen-Feng [1 ,2 ]
Wu, Ling-Feng [2 ]
Xiang, Zheng-Bing [2 ]
Liu, Shi-Min [2 ]
Liu, Hai-Yan [1 ,2 ]
Pan, Yang [1 ,2 ]
Nie, Feng [2 ]
Wu, Xiao-Mu [2 ]
Xie, Xu-Fang [2 ]
机构
[1] Nanchang Univ, Jiangxi Med Coll, Dept Med, 92 Aiguo Rd, Nanchang 330006, Jiangxi, Peoples R China
[2] Jiangxi Prov Peoples Hosp, Dept Neurol, 92 Aiguo Rd, Nanchang 330006, Jiangxi, Peoples R China
关键词
acute ischemic stroke; glycated hemoglobin index; intravenous thrombolysis; mean arterial pressure; prognosis; recombinant tissue plasminogen activator; POOLED ANALYSIS; ALTEPLASE; PREDICTS; DRAGON; ECASS; HYPERGLYCEMIA; SCORES; NINDS; SAFE; HEAD;
D O I
10.1097/MD.0000000000013216
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine whether glycated hemoglobin and mean arterial pressure (MAP) during thrombolysis are prognostic factors of intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) for acute ischemic stroke (AIS). A total of 125 AIS patients, who received rt-PA intravenous thrombolysis in our hospital, were included into the present study, and divided into good prognosis group and poor prognosis group. Univariate and multivariate logistic regression analyses were used to determine the prognostic factors of AIS treated by rt-PA thrombolysis, Spearman correlation analysis was used to analyze the correlation of the accumulated cigarette consumption in the smoking subgroup and glycated hemoglobin in the diabetic subgroup with the prognosis after intravenous thrombolysis and the symptomatic intracranial hemorrhage (sICH). Univariate analysis revealed that the interval from onset to thrombolysis, baseline National Institutes of Health Stroke Scale (NIHSS) score, MAP during thrombolysis and DRAGON score were prognostic factors. Multivariate logistic regression analysis revealed that baseline NIHSS score and MAP during thrombolysis were independent prognostic factors for rt-PA thrombolysis. Furthermore, the glycated hemoglobin index was positively correlated with the incidence of sICH. The NIHSS score before thrombolysis and MAP during thrombolysis were independent factors for the prognosis of AIS treated by thrombolysis. The higher the glycated hemoglobin index of diabetic patients, the more likely they are to develop sICH, the glycated hemoglobin index was negatively correlated with the prognosis after intravenous thrombolysis. The accumulated cigarette consumption was negatively correlated with the prognosis after intravenous thrombolysis.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Safety and effectiveness of intravenous thrombolysis with recombinant tissue plasminogen activator in eighty years and older acute ischemic stroke patients
    Chen, Y.
    Li, C. -H.
    Wang, Y. -X.
    Zhang, C. -H.
    Dong, Z.
    Zhang, F. -F.
    Wang, J. -H.
    Zhang, P. -L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (10) : 1852 - 1858
  • [2] Intravenous Thrombolysis with Recombinant Tissue-type Plasminogen Activator for Acute Ischemic Stroke in Patients with Metabolic Syndrome
    Sobolewski, Piotr
    Brola, Waldemar
    Szczuchniak, Wiktor
    Fudala, Magorzata
    Kozera, Grzegorz
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (08) : 1787 - 1792
  • [3] Effect of standardized nursing cooperation on intravenous thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke
    Yin, Chunhong
    Qi, Li
    Jing, Xia
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (10): : 11925 - 11931
  • [4] The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke
    Kahn, JH
    Viereck, J
    Kase, C
    Jeerakathil, T
    Romero, R
    Mehta, SD
    Kociol, R
    Babikian, V
    JOURNAL OF EMERGENCY MEDICINE, 2005, 29 (03) : 273 - 277
  • [5] Update on Intravenous Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
    Fugate, Jennifer E.
    Rabinstein, Alejandro A.
    MAYO CLINIC PROCEEDINGS, 2014, 89 (07) : 960 - 972
  • [6] Safety and Effectiveness of Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in 80 Years and Older Acute Ischemic Stroke Patients
    Yan Chen
    Chen-hua Li
    Yu-Xin Wang
    Chen-Hao Zhang
    Zhong Dong
    Fang-fang Zhang
    Jin-Huan Wang
    Pei-Lan Zhang
    Cell Biochemistry and Biophysics, 2015, 72 : 883 - 888
  • [7] Safety and Effectiveness of Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in 80 Years and Older Acute Ischemic Stroke Patients
    Chen, Yan
    Li, Chen-hua
    Wang, Yu-Xin
    Zhang, Chen-Hao
    Dong, Zhong
    Zhang, Fang-fang
    Wang, Jin-Huan
    Zhang, Pei-Lan
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 72 (03) : 883 - 888
  • [8] Factors influencing clinical outcomes of acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator
    Huang Yin-hui
    Zhuo Shi-tu
    Chen Ya-fang
    Li Ming-mei
    Lin You-yu
    Yang Mei-li
    Chen Zhen-jie
    Cai Ruo-wei
    CHINESE MEDICAL JOURNAL, 2013, 126 (24) : 4685 - 4690
  • [9] Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis in a Patient with Acute Ischemic Stroke Secondary to Aortic Dissection
    Hong, Keun-Sik
    Park, So-Young
    Whang, Seon-Il
    Seo, So-Young
    Lee, Dong-Ha
    Kim, Han-Joon
    Cho, Joong-Yang
    Cho, Yong-Jin
    Jang, Woo-Ik
    Kim, Chang Young
    JOURNAL OF CLINICAL NEUROLOGY, 2009, 5 (01): : 49 - 52
  • [10] Intravenous Thrombolysis With Low-Dose Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Response
    Toyoda, Kazunori
    Koga, Masatoshi
    Minematsu, Kazuo
    STROKE, 2010, 41 (03) : E165 - E165